These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

479 related items for PubMed ID: 11382623

  • 1. Comparison of once- or twice-daily bimatoprost with twice-daily timolol in patients with elevated IOP : a 3-month clinical trial.
    Brandt JD, VanDenburgh AM, Chen K, Whitcup SM, Bimatoprost Study Group.
    Ophthalmology; 2001 Jun; 108(6):1023-31; discussion 1032. PubMed ID: 11382623
    [Abstract] [Full Text] [Related]

  • 2. Six-month comparison of bimatoprost once-daily and twice-daily with timolol twice-daily in patients with elevated intraocular pressure.
    Sherwood M, Brandt J, Bimatoprost Study Groups 1 and 2.
    Surv Ophthalmol; 2001 May; 45 Suppl 4():S361-8. PubMed ID: 11434939
    [Abstract] [Full Text] [Related]

  • 3. A 3-month randomized controlled trial of bimatoprost (LUMIGAN) versus combined timolol and dorzolamide (Cosopt) in patients with glaucoma or ocular hypertension.
    Coleman AL, Lerner F, Bernstein P, Whitcup SM.
    Ophthalmology; 2003 Dec; 110(12):2362-8. PubMed ID: 14644719
    [Abstract] [Full Text] [Related]

  • 4. A randomised, double masked, multicentre clinical trial comparing bimatoprost and timolol for the treatment of glaucoma and ocular hypertension.
    Whitcup SM, Cantor LB, VanDenburgh AM, Chen K.
    Br J Ophthalmol; 2003 Jan; 87(1):57-62. PubMed ID: 12488264
    [Abstract] [Full Text] [Related]

  • 5. 24-Hour IOP control with once-daily bimatoprost, timolol gel-forming solution, or latanoprost: a 1-month, randomized, comparative clinical trial.
    Walters TR, DuBiner HB, Carpenter SP, Khan B, VanDenburgh AM, Bimatoprost Circadian IOP Study Group.
    Surv Ophthalmol; 2004 Mar; 49 Suppl 1():S26-35. PubMed ID: 15016559
    [Abstract] [Full Text] [Related]

  • 6. Long-term efficacy and safety of bimatoprost for intraocular pressure lowering in glaucoma and ocular hypertension: year 4.
    Williams RD, Cohen JS, Gross RL, Liu CC, Safyan E, Batoosingh AL, Bimatoprost Study Group.
    Br J Ophthalmol; 2008 Oct; 92(10):1387-92. PubMed ID: 18621791
    [Abstract] [Full Text] [Related]

  • 7. Comparison of the ocular hypotensive lipid AGN 192024 with timolol: dosing, efficacy, and safety evaluation of a novel compound for glaucoma management.
    Laibovitz RA, VanDenburgh AM, Felix C, David R, Batoosingh A, Rosenthal A, Cheetham J.
    Arch Ophthalmol; 2001 Jul; 119(7):994-1000. PubMed ID: 11448321
    [Abstract] [Full Text] [Related]

  • 8. Comparison of travoprost 0.0015% and 0.004% with timolol 0.5% in patients with elevated intraocular pressure: a 6-month, masked, multicenter trial.
    Fellman RL, Sullivan EK, Ratliff M, Silver LH, Whitson JT, Turner FD, Weiner AL, Davis AA, Travoprost Study Group.
    Ophthalmology; 2002 May; 109(5):998-1008. PubMed ID: 11986110
    [Abstract] [Full Text] [Related]

  • 9. A 1-year study to compare the efficacy and safety of once-daily travoprost 0.004%/timolol 0.5% to once-daily latanoprost 0.005%/timolol 0.5% in patients with open-angle glaucoma or ocular hypertension.
    Topouzis F, Melamed S, Danesh-Meyer H, Wells AP, Kozobolis V, Wieland H, Andrew R, Wells D.
    Eur J Ophthalmol; 2007 May; 17(2):183-90. PubMed ID: 17415690
    [Abstract] [Full Text] [Related]

  • 10. Comparison of topical travoprost eye drops given once daily and timolol 0.5% given twice daily in patients with open-angle glaucoma or ocular hypertension.
    Goldberg I, Cunha-Vaz J, Jakobsen JE, Nordmann JP, Trost E, Sullivan EK, International Travoprost Study Group.
    J Glaucoma; 2001 Oct; 10(5):414-22. PubMed ID: 11711841
    [Abstract] [Full Text] [Related]

  • 11. One-year, randomized study comparing bimatoprost and timolol in glaucoma and ocular hypertension.
    Higginbotham EJ, Schuman JS, Goldberg I, Gross RL, VanDenburgh AM, Chen K, Whitcup SM, Bimatoprost Study Groups 1 and 2.
    Arch Ophthalmol; 2002 Oct; 120(10):1286-93. PubMed ID: 12365906
    [Abstract] [Full Text] [Related]

  • 12. Efficacy and tolerability of fixed-combination bimatoprost/timolol versus fixed-combination dorzolamide/brimonidine/timolol in patients with primary open-angle glaucoma or ocular hypertension: a multicenter, prospective, crossover study.
    García-López A, Paczka JA, Jiménez-Román J, Hartleben C.
    BMC Ophthalmol; 2014 Dec 19; 14():161. PubMed ID: 25527295
    [Abstract] [Full Text] [Related]

  • 13. Two-year double-masked comparison of bimatoprost with timolol in patients with glaucoma or ocular hypertension.
    Cohen JS, Gross RL, Cheetham JK, VanDenburgh AM, Bernstein P, Whitcup SM.
    Surv Ophthalmol; 2004 Mar 19; 49 Suppl 1():S45-52. PubMed ID: 15016561
    [Abstract] [Full Text] [Related]

  • 14. A six-month randomized clinical trial comparing the intraocular pressure-lowering efficacy of bimatoprost and latanoprost in patients with ocular hypertension or glaucoma.
    Noecker RS, Dirks MS, Choplin NT, Bernstein P, Batoosingh AL, Whitcup SM, Bimatoprost/Latanoprost Study Group.
    Am J Ophthalmol; 2003 Jan 19; 135(1):55-63. PubMed ID: 12504698
    [Abstract] [Full Text] [Related]

  • 15. Efficacy and tolerability of timolol maleate ophthalmic gel-forming solution versus timolol ophthalmic solution in adults with open-angle glaucoma or ocular hypertension: a six-month, double-masked, multicenter study.
    Shedden A, Laurence J, Tipping R, Timoptic-XE 0.5% Study Group.
    Clin Ther; 2001 Mar 19; 23(3):440-50. PubMed ID: 11318078
    [Abstract] [Full Text] [Related]

  • 16. Topical bimatoprost: a review of its use in open-angle glaucoma and ocular hypertension.
    Easthope SE, Perry CM.
    Drugs Aging; 2002 Mar 19; 19(3):231-48. PubMed ID: 12027782
    [Abstract] [Full Text] [Related]

  • 17. A comparison of the safety and intraocular pressure lowering of bimatoprost/timolol fixed combination versus latanoprost/timolol fixed combination in patients with open-angle glaucoma.
    Martinez A, Sanchez M.
    Curr Med Res Opin; 2007 May 19; 23(5):1025-32. PubMed ID: 17519068
    [Abstract] [Full Text] [Related]

  • 18. A comparison of latanoprost, bimatoprost, and travoprost in patients with elevated intraocular pressure: a 12-week, randomized, masked-evaluator multicenter study.
    Parrish RK, Palmberg P, Sheu WP, XLT Study Group.
    Am J Ophthalmol; 2003 May 19; 135(5):688-703. PubMed ID: 12719078
    [Abstract] [Full Text] [Related]

  • 19. The safety and efficacy of travoprost 0.004%/timolol 0.5% fixed combination ophthalmic solution.
    Barnebey HS, Orengo-Nania S, Flowers BE, Samples J, Mallick S, Landry TA, Bergamini MV.
    Am J Ophthalmol; 2005 Jul 19; 140(1):1-7. PubMed ID: 15990081
    [Abstract] [Full Text] [Related]

  • 20. Phase 3 Randomized Clinical Trial of the Safety and Efficacy of Travoprost Intraocular Implant in Patients with Open-Angle Glaucoma or Ocular Hypertension.
    Sarkisian SR, Ang RE, Lee AM, Berdahl JP, Heersink SB, Burden JH, Doan LV, Stephens KG, Kothe AC, Usner DW, Katz LJ, Navratil T, GC-010 Travoprost Intraocular Implant Investigators.
    Ophthalmology; 2024 Sep 19; 131(9):1021-1032. PubMed ID: 38423216
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.